English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Medicine Clinical Trials
HighTide Therapeutics Raises $107 Million in Series C/C+ Financing to Advance Innovative Pipeline and Business Collaborations
Jan 05, 2023 18:00 HKT
逆勢融資1億+美元,這家創新藥Biotech有何獨特之處?
Jan 05, 2023 11:52 HKT
逆势融资1亿+美元,这家创新药Biotech有何独特之处?
Jan 05, 2023 11:51 HKT
君聖泰完成1.07 億美元C/C+輪融資,加速推進在研管線的全球開發、商業化和商務拓展
Jan 05, 2023 08:01 HKT
君圣泰完成1.07 亿美元C/C+轮融资,加速推进在研管线的全球开发、商业化和商务拓展
Jan 05, 2023 08:00 HKT
노보텍, 생명공학 쇼케이스 2023의 골드 스폰서
Dec 21, 2022 07:00 HKT
Novotech 是 Biotech Showcase 2023 的金牌赞助商
Dec 20, 2022 15:00 HKT
Novotech 是 Biotech Showcase 2023 的金牌贊助商
Dec 20, 2022 15:00 HKT
Novotech is Gold Sponsor at Biotech Showcase 2023
Dec 20, 2022 11:00 HKT
数据显示 50% 的新试验位于亚太地区
Dec 16, 2022 07:00 HKT
數據顯示 50% 的新試驗位於亞太地區
Dec 16, 2022 07:00 HKT
자료 보고, 새로운 임상 시험 중 50%의 시험 장소가 아시아 태평양 지역에 위치
Dec 16, 2022 07:00 HKT
Data Shows 50% of New Trials Have Sites in Asia Pacific
Dec 15, 2022 10:00 HKT
Preventing Strokes and Heart Attacks Doesn't Have to Come with the Risk of Life-threatening Bleeding
Dec 14, 2022 21:45 HKT
Novotech 荣获 2022 年亚太地区 CRO 临床试验最佳实践奖
Dec 07, 2022 06:00 HKT
Novotech 榮獲 2022 年亞太地區 CRO 臨床試驗最佳實踐獎
Dec 07, 2022 06:00 HKT
노보텍, 임상 시험 모범 사례로 2022년 아시아 태평양 CRO 상 수상
Dec 07, 2022 06:00 HKT
Novotech Awarded the Asia Pacific CRO of the Year 2022 for Best Practices in Clinical Trials
Dec 06, 2022 11:00 HKT
AJG Publishes Data from HighTide Therapeutics' Phase 2 Study of HTD1801 Treatment in Primary Sclerosing Cholangitis
Nov 17, 2022 08:00 HKT
Novotech, 동서 MRCT 전략 구축 및 자금 조달 방법에 대한 바이오 센추리 정상회담 워크숍 의장
Nov 12, 2022 14:00 HKT
<< Previous  Next >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: